NCT02504827View on ClinicalTrials.gov

Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

Ceftazidime/avibactam

Ceftazidime/avibactam 2.5gm iv q8h for 3 doses

Trial Locations (1)

90089

University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT02504827 - Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis | Biotech Hunter | Biotech Hunter